SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-010859
Filing Date
2018-08-02
Accepted
2018-08-02 16:11:49
Documents
70
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1079439
2 ex31.htm EX-31 48264
3 ex32.htm EX-32 11913
  Complete submission text file 0001493152-18-010859.txt   4680172

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE btx-20180630.xml EX-101.INS 666144
5 XBRL SCHEMA FILE btx-20180630.xsd EX-101.SCH 55858
6 XBRL CALCULATION FILE btx-20180630_cal.xml EX-101.CAL 78904
7 XBRL DEFINITION FILE btx-20180630_def.xml EX-101.DEF 281274
8 XBRL LABEL FILE btx-20180630_lab.xml EX-101.LAB 365076
9 XBRL PRESENTATION FILE btx-20180630_pre.xml EX-101.PRE 318244
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 5105213390
BIOTIME INC (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12830 | Film No.: 18988415
SIC: 2836 Biological Products, (No Diagnostic Substances)